Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Icu Medical (ICUI) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to $24.7 million.

  • Icu Medical's Shares Outstanding (Weighted Average) rose 101.48% to $24.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.7 million, marking a year-over-year increase of 101.48%. This contributed to the annual value of $24.4 million for FY2024, which is 123.28% up from last year.
  • Per Icu Medical's latest filing, its Shares Outstanding (Weighted Average) stood at $24.7 million for Q3 2025, which was up 101.48% from $24.6 million recorded in Q2 2025.
  • Icu Medical's Shares Outstanding (Weighted Average)'s 5-year high stood at $24.7 million during Q3 2025, with a 5-year trough of $21.1 million in Q1 2021.
  • In the last 5 years, Icu Medical's Shares Outstanding (Weighted Average) had a median value of $24.1 million in 2023 and averaged $23.6 million.
  • In the last 5 years, Icu Medical's Shares Outstanding (Weighted Average) skyrocketed by 1272.17% in 2022 and then soared by 74.49% in 2023.
  • Icu Medical's Shares Outstanding (Weighted Average) (Quarter) stood at $21.2 million in 2021, then rose by 12.55% to $23.9 million in 2022, then grew by 0.93% to $24.1 million in 2023, then grew by 1.23% to $24.4 million in 2024, then increased by 1.22% to $24.7 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $24.7 million in Q3 2025, compared to $24.6 million in Q2 2025 and $24.5 million in Q1 2025.